Skip to content

Commit b9db702

Browse files
Merge pull request #192 from bcgsc/data/KBDEV-1387-remove-forgotten-evidencelevel-links
Remove forgotten EvidenceLevel links in data
2 parents 873dd44 + 5173b01 commit b9db702

File tree

1 file changed

+5
-66
lines changed

1 file changed

+5
-66
lines changed

data/evidenceLevels.json

Lines changed: 5 additions & 66 deletions
Original file line numberDiff line numberDiff line change
@@ -299,6 +299,11 @@
299299
"description": "Evidence pertaining to biomarkers associated with FDA-approved therapies or professional guidelines for this tumour type",
300300
"displayName": "IPR-A",
301301
"links": [
302+
{
303+
"class": "CrossReferenceOf",
304+
"source": "ipr",
305+
"target": "cgi-cpic guidelines"
306+
},
302307
{
303308
"class": "CrossReferenceOf",
304309
"source": "ipr",
@@ -725,32 +730,6 @@
725730
},
726731
"moa-inferential": {
727732
"displayName": "MOAlmanac Inferential",
728-
"links": [
729-
{
730-
"class": "CrossReferenceOf",
731-
"target": "civic-e1"
732-
},
733-
{
734-
"class": "CrossReferenceOf",
735-
"target": "civic-e2"
736-
},
737-
{
738-
"class": "CrossReferenceOf",
739-
"target": "civic-e3"
740-
},
741-
{
742-
"class": "CrossReferenceOf",
743-
"target": "civic-e4"
744-
},
745-
{
746-
"class": "CrossReferenceOf",
747-
"target": "civic-e5"
748-
},
749-
{
750-
"class": "CrossReferenceOf",
751-
"target": "profyle-t5"
752-
}
753-
],
754733
"name": "Inferential",
755734
"source": "moa",
756735
"sourceId": "Inferential"
@@ -909,16 +888,6 @@
909888
"profyle-t2": {
910889
"description": "Biomarkers that predict response or resistance to therapies based on well-powered clinical trials",
911890
"displayName": "PROFYLE T2",
912-
"links": [
913-
{
914-
"class": "CrossReferenceOf",
915-
"target": "profyle-t2a"
916-
},
917-
{
918-
"class": "CrossReferenceOf",
919-
"target": "profyle-t2b"
920-
}
921-
],
922891
"name": "PROFYLE Therapeutic Level 2",
923892
"source": "profyle",
924893
"sourceId": "T2"
@@ -942,16 +911,6 @@
942911
"profyle-t3": {
943912
"description": "Biomarkers that predict response or resistance to therapies based on small series, case-reports, or that serve as inclusion criteria for a clinical trial",
944913
"displayName": "PROFYLE T3",
945-
"links": [
946-
{
947-
"class": "CrossReferenceOf",
948-
"target": "profyle-t3a"
949-
},
950-
{
951-
"class": "CrossReferenceOf",
952-
"target": "profyle-t3b"
953-
}
954-
],
955914
"name": "PROFYLE Therapeutic Level 3",
956915
"source": "profyle",
957916
"sourceId": "T3"
@@ -975,16 +934,6 @@
975934
"profyle-t4": {
976935
"description": "Biomarkers that show plausible therapeutic significance based on preclinical studies",
977936
"displayName": "PROFYLE T4",
978-
"links": [
979-
{
980-
"class": "CrossReferenceOf",
981-
"target": "profyle-t4a"
982-
},
983-
{
984-
"class": "CrossReferenceOf",
985-
"target": "profyle-t4b"
986-
}
987-
],
988937
"name": "PROFYLE Therapeutic Level 4",
989938
"preclinical": true,
990939
"source": "profyle",
@@ -1011,16 +960,6 @@
1011960
"profyle-t5": {
1012961
"description": "Novel biomarkers predicted to be oncogenic in therapeutically actionable genes, or evidence of activation of a therapeutically actionable pathway",
1013962
"displayName": "PROFYLE T5",
1014-
"links": [
1015-
{
1016-
"class": "CrossReferenceOf",
1017-
"target": "profyle-t5a"
1018-
},
1019-
{
1020-
"class": "CrossReferenceOf",
1021-
"target": "profyle-t5b"
1022-
}
1023-
],
1024963
"name": "PROFYLE Therapeutic Level 5",
1025964
"source": "profyle",
1026965
"sourceId": "T5"

0 commit comments

Comments
 (0)